Research Communication

Similar documents
mirna Dr. S Hosseini-Asl

MicroRNA-182 targets camp-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma

Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through mir-93/ PTEN/Akt Signaling Pathway

MicroRNA dysregulation in cancer. Systems Plant Microbiology Hyun-Hee Lee

Ling Xu, Wei-Qi Dai, Xuan-Fu Xu, Fan Wang, Lei He, Chuan-Yong Guo*

MicroRNA in Cancer Karen Dybkær 2013

MicroRNA and Male Infertility: A Potential for Diagnosis

mir 375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression

Profiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola

Original Article Identification of IRF1, PPP2R5E and IL-6R, the target genes of mir-23a in gastric cancer cells

Cellular Physiology and Biochemistry

Original Article mir-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

Research Communication

PUMA gene transfection can enhance the sensitivity of epirubicin-induced apoptosis of MCF-7 breast cancer cells

Original Article MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2

Influence of RNA Interference Targeting Rab5a on Proliferation and Invasion of Breast Cancer Cell Line MCF-7

Increased mir-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis

Low levels of serum mir-99a is a predictor of poor prognosis in breast cancer

Regulation of the transcription factor NF-kappaB1 by microrna-9 in human gastric adenocarcinoma

HCC1937 is the HCC1937-pcDNA3 cell line, which was derived from a breast cancer with a mutation

MicroRNAs: novel regulators in skin research

mir-132 inhibits lung cancer cell migration and invasion by targeting SOX4

Soft Agar Assay. For each cell pool, 100,000 cells were resuspended in 0.35% (w/v)

Downregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases

microrna Presented for: Presented by: Date:

Supplementary Materials and Methods

Supplementary Figure S1. Venn diagram analysis of mrna microarray data and mirna target analysis. (a) Western blot analysis of T lymphoblasts (CLS)

MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells

ONCOLOGY LETTERS 15: , 2018

microrna 761 regulates glycogen synthase kinase 3β expression and promotes the proliferation and cell cycle of human gastric cancer cells

HEK293FT cells were transiently transfected with reporters, N3-ICD construct and

micrornas (mirna) and Biomarkers

microrna-200b and microrna-200c promote colorectal cancer cell proliferation via

Bmi-1 regulates stem cell-like properties of gastric cancer cells via modulating mirnas

Regulation of the transcription factor NF- B1 by microrna-9 in human gastric adenocarcinoma

Reduced mirna-218 expression in pancreatic cancer patients as a predictor of poor prognosis

Post-transcriptional regulation of an intronic microrna

Expression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer

Original Article MiR-130a regulates the proliferation and metastasis of HCC cells through targeting ZEB1/2

Epstein-Barr virus driven promoter hypermethylated genes in gastric cancer

Supplementary information

MicroRNA-30a functions as tumor suppressor and inhibits the proliferation and invasion of prostate cancer cells by down-regulation of SIX1

The inhibitory effect of mir-375 targeting sp1 in colorectal cancer cell proliferation

Effects of metallothionein-3 and metallothionein-1e gene transfection on proliferation, cell cycle, and apoptosis of esophageal cancer cells

LncSNHG14 promotes the development and progression of bladder cancer by targeting mirna-150-5p

MicroRNA-338-3p inhibits glucocorticoidinduced osteoclast formation through RANKL targeting

CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer

Inhibition of the Growth of Raji Cells by Precursor MicroRNA-15a

TITLE: MiR-146-SIAH2-AR Signaling in Castration-Resistant Prostate Cancer

Knockdown of Long Noncoding RNA LUCAT1 Inhibits Cell Viability and Invasion by Regulating mir-375 in Glioma

LncRNA LET function as a tumor suppressor in breast cancer development

Supplementary Figure 1

Lentiviral Delivery of Combinatorial mirna Expression Constructs Provides Efficient Target Gene Repression.

Circular RNAs (circrnas) act a stable mirna sponges

Supplementary data Supplementary Figure 1 Supplementary Figure 2

mir 483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5

(,, ) microrna(mirna) 19~25 nt RNA, RNA mirna mirna,, ;, mirna mirna. : microrna (mirna); ; ; ; : R321.1 : A : X(2015)

mir-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2

Cellular MicroRNA and P Bodies Modulate Host-HIV-1 Interactions. 指導教授 : 張麗冠博士 演講者 : 黃柄翰 Date: 2009/10/19

mir-17 in imatinib resistance and response to tyrosine kinase inhibitors in chronic myeloid leukemia cells

10/31/2017. micrornas and cancer. From the one gene-one enzyme hypothesis to. microrna DNA RNA. Transcription factors.

The Biology and Genetics of Cells and Organisms The Biology of Cancer

mir-206 Expression Is Down-regulated in Estrogen Receptor A Positive Human Breast Cancer

Alternative regulation of MYC in lung cancer

Mir-138-5p acts as a tumor suppressor by targeting pyruvate dehydrogenase kinase 1 in human retinoblastoma

Doctoral Degree Program in Marine Biotechnology, College of Marine Sciences, Doctoral Degree Program in Marine Biotechnology, Academia Sinica, Taipei,

Bi 8 Lecture 17. interference. Ellen Rothenberg 1 March 2016

Long noncoding RNA DARS-AS1 acts as an oncogene by targeting mir-532-3p in ovarian cancer

Mir-595 is a significant indicator of poor patient prognosis in epithelial ovarian cancer

MiR-136 triggers apoptosis in human gastric cancer cells by targeting AEG-1 and BCL2

Long non coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating mir 32 5p/PTEN axis

Phenomena first observed in petunia

Original Article MiR p suppresses glioma migration and invasion by regulating p-cadherin

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

MicroRNAs and Cancer

mir-19a promotes colorectal cancer proliferation and migration by targeting TIA1

BIO360 Fall 2013 Quiz 1

MicroRNA 98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k Ras/Raf/MEK/ERK signaling pathway

Original Article microrna-377 inhibits non-small-cell lung cancer through targeting AEG-1

Mechanism of mirna-21-5p on apoptosis of IL-1β- induced rat. synovial cells

MicroRNA-mediated incoherent feedforward motifs are robust

supplementary information

m 6 A mrna methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer

Research on the inhibitory effect of metformin on human oral squamous cell carcinoma SCC-4 and CAL-27 cells and the relevant molecular mechanism.

mir-187 inhibits the growth of cervical cancer cells by targeting FGF9

Decreased expression of mir-490-3p in osteosarcoma and its clinical significance

MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3

MicroRNA 124 3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1

microrna 181 promotes prostate cancer cell proliferation by regulating DAX 1 expression

MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47

Overexpression of mir-708 and Its Targets in the Childhood Common Precursor B-Cell ALL

Original Article MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4)

Detection of let-7a MicroRNA by Real-time PCR in Colorectal Cancer: a Single-centre Experience from China

Pleiotrophin, a target of mir-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma

Construction of a hepatocellular carcinoma cell line that stably expresses stathmin with a Ser25 phosphorylation site mutation

Original Article microrna-155 acts as an oncogene by targeting the tumor protein 53-induced nuclear protein 1 in esophageal squamous cell carcinoma

Deciphering the Role of micrornas in BRD4-NUT Fusion Gene Induced NUT Midline Carcinoma

MicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL

High AU content: a signature of upregulated mirna in cardiac diseases

Transcription:

IUBMB Life, 64(7): 628 635, July 2012 Research Communication MicroRNA-181b Targets camp Responsive Element Binding Protein 1 in Gastric Adenocarcinomas Lin Chen*, Qian Yang*, Wei-Qing Kong*, Tao Liu, Min Liu, Xin Li and Hua Tang Tianjin Life Science Research Center and Basic Medical School, Tianjin Medical University, Tianjin, China Summary MicroRNAs are a class of small endogenous non-coding RNAs that function as post-transcriptional regulators. In our previous study, we found that mir-181b was significantly downregulated in human gastric adenocarcinoma tissue samples compared to the adjacent normal gastric tissues. In this study, we confirm the down-regulation of mir-181b in human gastric cancer cell lines versus the gastric epithelial cells. Overexpression of mir-181b suppressed the proliferation and colony formation rate of gastric cancer cells. mir-181b downregulated the expression of camp responsive element binding protein 1 (CREB1) by binding its 3 untranslated region. Overexpression of CREB1 counteracted the suppression of growth in gastric cancer cells caused by ectopic expression of mir-181b. These results indicate that mir-181b may function as a tumor suppressor in gastric adenocarcinoma cells through negative regulation of CREB1. Ó 2012 IUBMB IUBMB Life, 64(7): 628 635, 2012 Keywords Abbreviations mirna; mir-181b; camp responsive element binding protein 1; cell growth; gastric carcinoma. ASO, antisense oligonucleotide; CREB1, camp responsive element binding protein 1; EGFP, enhanced green fluorescence protein; GAPDH, glyceraldehyde phosphate dehydrogenase; mir-181b, microrna- 181b; mirna, microrna; UTR, untranslated region. INTRODUCTION Gastric cancer is the second leading cause of cancer-related mortality worldwide (1). Gastric adenocarcinoma is derived from the gastric epithelium mucosal cells, occupies 95% of the Additional Supporting Information may be found in the online version of this article. Received 22 November 2011; accepted 24 February 2012 *The authors are contributed equally to this work. Address correspondence to: Hua Tang, Tianjin Life Science Research Center and Basic Medical School, Tianjin Medical University, 22 Qi- Xiang-Tai Road, Tianjin 300070, China. Tel./Fax: 186 22 23542503. E-mail: htang2002@yahoo.com gastric malignant tumor, and is the most common form of gastric cancer. Multiple factors are involved in the development of gastric carcinogenesis including inactivation of tumor suppressor genes, activation of oncogenes, and abnormalities of cell cycle regulators and growth factors. MicroRNAs (mirnas) are a class of 22nt non-coding RNAs that regulate gene expression by interacting with complementary sites in the 3 untranslated region (3 UTR) of target genes (2). The genes encoding mirnas are transcribed into primary mirnas in the nucleus, predominantly by RNA polymerase II, and then cleaved by Drosha to produce stem-loop-structured precursor molecules (pre-mirnas). Pre-miRNAs are then exported to the cytoplasm where the RNase III enzyme, Dicer, further processes them into mature mirnas (22 nucleotides) (3). Recent studies have shown that dysregulated expression or mutation of mirnas were associated with various human cancers and have indicated that mirnas can function as tumor suppressor genes and oncogenes (4). Specifically in gastric cancers, mirnas have been shown to function as tumor suppressors or oncogenes (5). For example, mir-375 and mir-142-5p have been identified as classifiers used to recognize recurrence and non-recurrence in gastric cancer; a high frequency recurrence and poor survival were observed in gastric cancer cases with high levels of mir-375 and low levels of mir-142-5p (6). mir-9, which is downregulated in human gastric cancer cells, plays a role in regulating gastric cancer cell growth by targeting NF-jB1 (7). In our previous study, we found that mir-181b displayed prominent and coincident down-regulation in human gastric cancer tissues compared to the matched normal gastric tissues (8). In this study, we focused on the effects of mir-181b on the cellular phenotypes of MGC-803, BGC-823, and SGC-7901 gastric adenocarcinoma cell lines. Previous studies have identified CREB-regulated genes including many types of oncogenes (e.g., bcl-2), cell cycle related genes (e.g., cyclina1, cyclinb1, and cyclind2), signal transduction proteins, activated transcription factor 3, NF-jB, and other growth-related genes (9). camp responsive element binding protein 1(CREB1), a member of the ISSN 1521-6543 print/issn 1521-6551 online DOI: 10.1002/iub.1030

MIR-181B TARGETS CREB1 IN GASTRIC CANCER 629 CREB family of proteins, is an oncogene that promotes tumor cell growth and proliferation (10), and is found to be a target of mir-181b in this study. Our findings indicate that mir-181b functions as a tumor suppressor in gastric adenocarcinoma. MATERIALS AND METHODS mirna Target Prediction TargetScan, PicTar, and mirbase were used to predict mirna targets. Plasmid Construction and Oligonucleotides In this study, we constructed the following vectors: pcdna3/pri-mir-181b, ASO-miR-181b, pcdna3/ enhanced green fluorescence protein (EGFP)-CREB1-3 UTR, pcdna3/ EGFP-CREB1-3 UTR mutant and psilencer/shrna-creb1. The details of vector construction as well as the sequence of the oligonucleotides can be found in the Supporting Information. Tissue Samples, Cell Lines, and Transfection GES-1 (human gastric epithelial cells), MGC-803, BGC-823, and SGC-7901 cells were maintained in RPMI 1640 (GIBCO) with 10% heat-inactivated fetal bovine serum, 100 IU/mL penicillin, and 0.1 mg/ml streptomycin in a humidified 5% (v/v) atmosphere of CO 2 at 37 8C. Transfection was performed with Lipofectamine 2000 Reagent following the manufacturer s protocol (Invitrogen, Carlsbad, CA). Fluorescent Reporter Assay Cells were transfected with pri-mir-181b or the control vector, pcdna3, in 48-well plates in conjunction with the reporter vector pcdna3/egfp-creb1 3 UTR or pcdna3/egfp- CREB1 3 UTR-mut. Additionally, the ASO-miR-181b or ASO- NC vector was co-transfected into cells with the pcdna3/ EGFP-CREB1 3 UTR or pcdna3/egfp-creb1 3 UTR-mut vector. Also, the mir-181b mimics, mutated mir-181b (mir- 181b-mut) or mimics NC was co-transfected into cells with the pcdna3/egfp-creb1 3 UTR. The pdsred2-n1 vector (Clontech, Mountain View, CA) expressing RFP was spiked in and used for normalization. The intensities of EGFP and RFP fluorescence were detected with a Fluorescence Spectrophotometer F-4500 (Hitachi, Tokyo, Japan). The EGFP expression level was also measured by quantitative RT-PCR and Western blot assays. Quantitative RT-PCR The quantitative RT-PCR assays were performed to detect the relative levels of the CREB1 mrna and mature mir-181b (11). The details of the method are given in the Supporting Information. Western Blot Cultured cells were lysed in RIPA lysis buffer. Lysates were collected and cleared by centrifugation and the protein concentration was determined. Total cell lysates (50 lg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins were transferred onto nitrocellulose membranes. The membranes were incubated with an antibody against CREB1, EGFP, or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) overnight at 4 8C. Then, the membranes were incubated with goat anti-rabbit peroxidase-conjugated secondary antibody. Protein expression was assessed by enhanced chemiluminescence and exposure to chemiluminescent detection film. Antibodies were purchased from Tianjin Saier Biotech and Sigma-Aldrich. Cell Proliferation Assay MGC-803, BGC-823, and SGC-7901 cells were seeded in a 96-well plate at 6,000, 7,000, and 8,000 cells per well, respectively, one day before transfection. The cells were transfected with pri-mir-181b or the control vector at 0.15 lg per well. The MTT [(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay was used to determine cell viability 24, 48, and 72 H after transfection. The absorbance at 570 nm was measured using a lquant Universal Microplate Spectrophotometer (BioTek, Winooski, VT). Colony Formation Assay After transfection, MGC-803, BGC-823, and SGC-7901 cells were counted and seeded in 12-well plates (in triplicate) at 200, 150, and 250 cells per well, respectively. Culture medium was replaced every 3 days. Colonies were counted from the 6th day after seeding only if they contained more than 50 cells. Cells were stained using crystal violet. The rate of colony formation was calculated with the following equation: colony formation rate (%) 5 (number of colonies/number of seeded cells) 3 100. Statistical Analysis Data are expressed as the means 6 standard deviation (SD), and P \ 0.05 is considered statistically significant by Student s t test. RESULTS Downregulation of mir-181b in Human Gastric Adenocarcinoma and in Gastric Cancer Cell Lines Quantitative real-time PCR (qrt-pcr) was used to detect differential expression of mir-181b in 10 pairs of human gastric adenocarcinomas and corresponding adjacent normal tissues. Results showed that the mir-181b expression level in gastric adenocarcinoma is significantly lower than that in corresponding adjacent normal tissues (Fig. 1A). Meanwhile, we also determined that the expression of mir-181b in human gastric adenocarcinoma cells, MGC-803, BGC-823, and SGC-7901 cells was

630 CHEN ET AL. Figure 1. Deregulation of mir-181b in gastric adenocarcinoma tissue and suppression of mir-181b in gastric adenocarcinoma cell growth. (A) Differential expression of mir-181b in 10 pairs of human gastric adenocarcinomas and corresponding adjacent normal tissues. U6 snrna was used as an endogenous normalizer. (B) The relative expression level of mir-181b in MGC-803, BGC-823, SGC-7901, and GES-1 cells are shown. (C) The relative level of mir-181b in BGC-823 cells after transfection with pcdna3/primir-181b (pri-mir-181b), ASO-miR-181b, mir-181b mimics or mir-181b-mut, and the expression level of mature mir-181b was detected by quantitative RT-PCR. (D F) MGC-803 (D), BGC-823 (E), and SGC-7901 (F) cells were transfected with pri-mir-181b or ASO-miR-181b. Cell viability was determined at 24, 48, and 72 H post-transfection by the MTT assay. (G) MGC-803, BGC- 823, and SGC-7901 cells were transfected with pri-mir-181b or control vector. The cell growth capacity in vitro was assessed by the colony formation assay. (H) MGC-803, BGC-823, and SGC-7901 cells were transfected with ASO-miR-181b or control vector (*P \0.05, **P \0.005). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] lower than that in GES-1 human gastric epithelial cells using qrt-pcr (Fig. 1B). Overexpression of mir-181b Suppresses the Proliferation of Gastric Adenocarcinoma Cells To determine the effects of mir-181b on gastric adenocarcinoma cell proliferation, a mir-181b overexpression vector, a synthesized anti-mir inhibitor (ASO-miR-181b), synthesized mir-181b mimics and mir-181b-mut were used to alter the expression levels of mir-181b in gastric adenocarcinoma cells. First, we used quantitative RT-PCR to validate the expression of mir-181b in BGC-823 cells after transfection with pri-mir- 181b, ASO-miR-181b, mir-181b mimics or mir-181b-mut (Fig. 1C). To test the effects of mir-181b on cell viability and growth of gastric adenocarcinoma cells, we transfected the primir-181b or ASO-miR-181b into BGC-823 cells. The MTT assay showed that the enhanced level of mir-181b reduced the viability of MGC-803 cells by approximately 20% (Fig. 1D). In contrast, ASO-miR-181b increased the viability of MGC-803 cells by approximately 30% (Fig. 1D). The colony formation assay indicated that the colony formation rate of MGC-803 cells

MIR-181B TARGETS CREB1 IN GASTRIC CANCER 631 Figure 2. CREB1 is a direct target of mir-181b. (A) The predicted binding sites of mir-181b on the CREB1 mrna are shown. The mutated CREB1 3 UTR and mutated mir-181b are also shown. (B D) BGC-823 cells were transfected with the wild type pcdna3/egfp-creb1 3 UTR reporter vector along with pri-mir-181b or ASO-miR-181b. The EGFP expression was measured by fluorescence intensity (B), quantitative RT-PCR (C) and Western blot (D). (E G) BGC-823 cells were transfected with the mutated pcdna3/egfp-creb1-3 UTR (pcdna3/egfp-creb1-3 UTR-mut) reporter vector along with pri-mir-181b or ASOmiR-181b. H-J: BGC-823 cells were transfected with the wild type pcdna3/egfp-creb1 3 UTR reporter vector along with mir- 181b mimics or mir-181b mutant (mir-181b-mut) (*P < 0.05).

632 CHEN ET AL. Figure 3. mir-181b negatively regulates CREB1 at the post-transcriptional level. (A) BGC-823 cells were transfected with primir-181b or ASO-miR-181b, and the CREB1 protein expression level was evaluated by western blot. The GAPDH protein was used as an endogenous normalizer. (B) BGC-823 cells were transfected with pri-mir-181b or ASO-miR-181b, and expression of CREB1 mrna was measured by qrt-pcr. b-actin mrna was used as an endogenous normalizer. (C) The expression levels of CREB1 mrna in the 10 pairs of gastric adenocarcinoma tissues (Ca) and the matched normal tissues (N) were assessed by qrt- PCR. b-actin mrna was used as an endogenous normalizer (*P \ 0.05, ** P \0.005). transfected with pri-mir-181b was 30 40% lower than the control group (Fig. 1G), whereas the addition of ASO-miR-181b enhanced colony formation rates by approximately 30% in MGC-803 cells (Fig. 1H). Similar results were found in BGC- 823 and SGC-7901 cells (Figs. 1E 1H). These results demonstrate that mir-181b can suppress cell growth in gastric adenocarcinoma cells. mir-181b Binds Directly to the CREB1 3 UTR in Gastric Adenocarcinoma Cells To identify the target genes mediating the function of mir- 181b, bioinformatic methods were used to predict potential target genes. We found that the 3 UTR of the CREB1 mrna contains a mir-181b-complementary binding site (Fig. 2A). To validate that CREB1 can be directly targeted by mir-181b, we performed an EGFP reporter assay using engineered EGFP reporter vectors that had either the wild type 3 UTR of CREB1 or the mutant 3 UTR with a 4-base mutation in the complementary seed sequence. Also, mir-181b mimics and mir-181b mutant bearing four mutated bases are also synthesized (Fig. 2A). Overexpression of mir-181b by addition of pri-mir-181b significantly repressed EGFP expression compared to the control vector (Figs. 2B 2D), whereas downregulation of mir-181b with ASO-miR-181b significantly increased the intensity of EGFP fluorescence compared to the control group (Figs. 2B 2D). In contrast, with the mutated CREB1 3 UTR reporter vector, EGFP expression levels were not influenced by overexpression or downregulation of mir-181b (Figs. 2E 2G). To further confirm the direct binding between mir-181b and CREB1 3 UTR, we also mutated the mir-181b seed sequence. We found that mir-181b mimics could suppress EGFP expression from pcdna3/egfp-creb1 3 UTR, whereas mutated mir- 181b could not (Figs. 2H 2J). All the results indicated that mir-181b could bind to the seed sequence present in the CREB1 mrna 3 UTR and negatively regulate the expression of the CREB1 gene. mir-181b Negatively Regulates CREB1 at the Post Transcriptional Level To determine if mir-181b decreases endogenous CREB1 expression, we transfected BGC-823 cells with pri-mir-181b or ASO-miR-181b and examined the protein expression of CREB1 by western blot analysis. The results indicated that overexpression of mir-181b reduced the expression level of the CREB1 protein by 30% (Fig. 3A) and qrt-pcr indicated a decrease in endogenous CREB1 mrna (Fig. 3B). Conversely, in BGC-823 cells transfected with ASO-miR-181b, the protein level of endogenous CREB1 was significantly increased (Fig. 3A), and the

MIR-181B TARGETS CREB1 IN GASTRIC CANCER 633 Figure 4. Knockdown of CREB1 inhibits cell growth in gastric adenocarcinoma cell lines. (A) Transfection with the psilencer/sir- CREB1 reduced CREB1 protein levels in BGC-823 cells compared with the control group. (B D) MTT assay analysis showed that transfection with the pcdna3/sir-creb1 plasmid suppressed cell viability in MGC-803 cells (B), BGC-823 cells (C), and SGC- 7901 cells (D). (E) Colony formation assay rates in MGC-803, BGC823, and SGC-7901 cells transfected with pcdna3/sir- CREB1 plasmid were lower compared with the control vector (*P \ 0.05, ** P \0.005). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] CREB1 mrna level was also elevated (Fig. 3B). In addition, we found that the expression level of CREB1 mrna in gastric adenocarcinoma tissues was significantly higher than in matching adjacent normal tissues in the 10 pairs of gastric tissues (Fig. 3C). Both the mrna and protein levels of CREB1 are responsive to the mir-181b level, indicating that mir-181b negatively regulates the expression of CREB1 mainly by the mrna degradation mechanism. Knockdown of CREB1 Inhibits Cell Growth in Gastric Adenocarcinoma Cells Previous studies have shown that CREB1 plays an important role in promoting tumor cell proliferation and functions as an oncogene in acute myeloid leukemia (12). To determine if CREB1 affects BGC-823 cell growth, we constructed the psilencer/sir-creb1 plasmid to knockdown the expression of CREB1. Western blot analysis indicated that the psilencer/sir- CREB1 plasmid could effectively reduce the CREB1 protein expression level in BGC-823 cells by approximately 20% (Fig. 4A). The MTT and colony formation assays indicated that CREB1 knockdown resulted in a reduction of cell viability and growth activity compared to the control group in MGC-803, BGC-823, and SGC-7901 cells (Figs. 4B 4E). Ectopic Expression of CREB1 Counteracts the Suppression of Cell Growth Caused by mir-181b in Gastric Cancer Cells To further confirm that mir-181b suppresses the growth of gastric cancer cells through downregulation of CREB1, we constructed the expression vector pcdna3/creb1 without the 3 UTR to avoid the mirna interference. Western blot analysis was used to validate the CREB1 expression in transfected BGC-823 cells (Fig. 5A). Ectopic expression of CREB1 was able to rescue the growth inhibition caused by mir-181b in

634 CHEN ET AL. Figure 5. Ectopic expression of CREB1 rescues the suppression of cell growth caused by mir-181b in gastric adenocarcinoma cell lines. (A) BGC-823 cells were transfected with pri-mir-181b and control vector, pri-mir-181b and either pcdna3/creb1 or pcdna3/creb1 and control vector. CREB1 protein levels were detected by western blot. The GAPDH protein was used as an endogenous normalizer. (B D) MGC-803 cells (B), BGC-823 cells (C), and SGC-7901 cells (D) were transfected with pcdna3/ CREB1 and pcdna3 with or without pri-mir-181b, and cell viability was determined using the MTT assay at 24, 48, and 72 H post-transfection. (E G) CREB1 ectopic expression reversed the cell growth suppression caused by mir-181b in the colony formation assay. MGC-803 cells (E), BGC-823 cells (F), and SGC-7901 cells (G) were transfected with pcdna3/creb1 and pcdna3 with or without pri-mir-181b and then seeded in 12-well plates. The colony formation rate is shown (*P \ 0.05, **P \0.005). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] MGC-803, BGC-823, and SGC-7901 cells (Figs. 5B 5D) as measured by the MTT and colony formation assays (Figs. 5E 5G). DISCUSSION mirnas are involved in a variety of cellular activities by negatively regulating specific target genes, and approximately one-third of human genes are believed to be mirna targets (13). Previous studies have shown that hsa-mir-181b functions as tumor suppressor that triggers growth inhibition, induces apoptosis, and inhibits invasion in glioma cells (14). It was also reported that mir-181b may contribute to multidrug resistance in human gastric and lung cancer cell lines by modulation of apoptosis via BCL2 targeting (15). As mir-181b was downregulated in gastric adenocarcinoma tissues (8), we here focused on the functions of mir-181b in gastric cancer cells and the regulation of its target genes. Initially, we used qrt-pcr to discover that mir-181b was significantly downregulated in human gastric adenocarcinoma tissue samples compared to corresponding adjacent normal tissues (Fig. 1A). The results suggested that mir-181b could play an important role in the development of gastric adenocarcinoma. Because of the low expression levels of mir-181b in cancer tissues, we speculated that mir-181b could be an inhibitory factor in gastric adenocarcinoma cells. To test this hypothesis, we used the MTT assay and colony formation assay to investigate the relationship between mir-181b and the growth capacity of gastric adenocarcinoma cell lines. The viability and the colony formation activity of MGC-803, BGC-823, and SGC-7901 cells transfected with the mir-181b overexpression vector (pri-mir-181b) were significantly decreased when compared to their control groups (Figs. 1D 1G). Moreover, ASO-miR-181b increased cell viability and colony formation activity when compared to ASO-NC (Figs. 1D 1F and 1H). Thus, we concluded that mir-181b functions as a tumor suppressor gene in gastric adenocarcinoma. Typically, mirnas affect cell processes by regulating target gene expression (2). To identify the target gene responsible for

MIR-181B TARGETS CREB1 IN GASTRIC CANCER 635 effects of mir-181b in gastric adenocarcinoma cells, we used bioinformatic analyses to predict a mir-181b binding site on the CREB1 transcript (Fig. 2A). Next, we used the fluorescence reporter assay to determine that CREB1 was indeed a target of mir-181b. The ability of mir-181b to regulate CREB1 expression was likely direct, because it bound the region of the CREB1 3 UTR that was complementary to the mir-181b seed region. The EGFP fluorescence intensity of EGFP-CREB1-3 UTR was specifically responsive to mir-181b alteration. However, mutation of either the mir-181b binding site on CREB1 3 UTR or the mir-181b itself could abolish the effect of mir-181b on the regulation of EGFP fluorescence intensity. Additionally, endogenous CREB1 expression was decreased at both the mrna and protein level in BGC-823 cells transfected with pri-mir-181b but increased in BGC-823 cells transfected with ASO-miR-181b (Figs. 3A and B). In addition, we observed an inverse correlation between the expression of mir-181b and CREB1 in tumor tissues and corresponding normal gastric tissues by qrt-pcr (Fig. 3C). These results indicate that mir- 181b regulates CREB1 expression by binding its 3 UTR directly. Cyclic AMP responsive element binding protein (CREB) family members are transcription factors which play critical roles in regulating numerous biological processes such as development, cancer, and memory formation (16, 17). CREB1 is one of the CREB family proteins that has been shown to be an oncogene that promotes tumor cell growth and proliferation. It can activate gene expression in a phosphorylation-dependent manner and bind as a dimer to a cyclic AMP-responsive element in the promoter region of target genes (18). Our findings uncover the relationship between mirnas and CREB1 in gastric adenocarcinoma cells. Knockdown of CREB1 suppresses the growth of three gastric cancer cell lines, which is consistent with the results of mir-181b overexpression. Ectopic expression of CREB1 rescues the suppression of cell growth caused by mir-181b. Thus, the low expression of mir-181b in gastric adenocarcinoma cells leads to an abnormally high expression level of the CREB1 oncogene resulting in cell proliferation. In summary, our results show that mir-181b functions as a tumor suppressor gene and inhibits cell proliferation in gastric adenocarcinoma cell lines. The low expression of mir-181b in gastric adenocarcinoma tissues leads to an abnormally high expression level of the CREB1 oncogene and results in the activation of cell proliferation. The elucidation of the effect of mir-181b on CREB1 regulation helps us to further understand the mechanism of gastric adenocarcinoma initiation and progression. ACKNOWLEDGEMENTS The authors like to thank the Tumor Bank Facility of Tianjin Medical University Cancer Institute and Hospital and National Foundation of Cancer Research (TBF of TMUCIH & NFCR) for providing human gastric tissue samples. They also thank the College of Public Health, Tianjin Medical University, for technical assistance with fluorescence detection. This work was supported by the National Natural Science Foundation of China (No. 30873017, No. 91029714, and No. 31071191) and the Natural Science Foundation of Tianjin (No. 08JCZDJC23300 and No. 09JCZDJC17500). REFERENCES 1. Parkin, D. M., Pisani, P., and Ferlay, J. (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80, 827 841. 2. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281 297. 3. Lee, Y., Jeon, K., Lee, J. T., Kim, S., and Kim, V. N. (2002) Micro- RNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663 4670. 4. Esquela-Kerscher, A., and Slack, F. J. (2006) Oncomirs - micrornas with a role in cancer. Nat. Rev. Cancer 6, 259 269. 5. Saito, Y., Suzuki, H., and Hibi, T. (2009) The role of micrornas in gastrointestinal cancers. J. Gastroenterol. 44 (Suppl 19), 18 22. 6. Zhang, X., Yan, Z., Zhang, J., Gong, L., Li, W., et al. (2011) Combination of hsa-mir-375 and hsa-mir-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann. Oncol. 22, 2257 2266. 7. Wan, H. Y., Guo, L. M., Liu, T., Liu, M., Li, X., et al. (2010) Regulation of the transcription factor NF-kappaB1 by microrna-9 in human gastric adenocarcinoma. Mol. Cancer 9, 16. 8. Liu, T., Tang, H., Lang, Y., Liu, M., and Li, X. (2009) MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett. 273, 233 242. 9. Zhang, X., Odom, D. T., Koo, S. H., Conkright, M. D., Canettieri, G., et al. (2005) Genome-wide analysis of camp-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl. Acad. Sci. USA 102, 4459 4464. 10. Crans-Vargas, H. N., Landaw, E. M., Bhatia, S., Sandusky, G., Moore, T. B., et al. (2002) Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. Blood 99, 2617 2619. 11. Chen, C., Ridzon, D. A., Broomer, A. J., Zhou, Z., Lee, D. H., et al. (2005) Real-time quantification of micrornas by stem-loop RT-PCR. Nucleic Acids Res. 33, e179. 12. Shankar, D. B., Cheng, J. C., Kinjo, K., Federman, N., Moore, T. B., et al. (2005) The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 7, 351 362. 13. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 120, 15 20. 14. Shi, L., Cheng, Z., Zhang, J., Li, R., Zhao, P., et al. (2008) hsa-mir- 181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 1236, 185 193. 15. Zhu, W., Shan, X., Wang, T., Shu, Y., and Liu, P. (2010) mir-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int. J. Cancer 127, 2520 2529. 16. Lonze, B. E. and Ginty, D. D. (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605 623. 17. Lee, Y. S., Bailey, C. H., Kandel, E. R., and Kaang, B. K. (2008) Transcriptional regulation of long-term memory in the marine snail Aplysia. Mol. Brain 1, 3. 18. Montminy, M. R. and Bilezikjian, L. M. (1987) Binding of a nuclear protein to the cyclic-amp response element of the somatostatin gene. Nature 328, 175 178.